Involvement of OX40 ligand+ mast cells in chronic GVHD after allogeneic hematopoietic stem cell transplantation.
Kotani
A
A
Hori
T
T
Fujita
T
T
Kambe
N
N
Matsumura
Y
Y
Ishikawa
T
T
Miyachi
Y
Y
Nagai
K
K
Tanaka
Y
Y
Uchiyama
T
T
D000293:Adolescent; D000328:Adult; D000943:Antigens, Differentiation / Q000276:immunology*; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D008297:Male; D008407:Mast Cells / Q000276:immunology*; D008875:Middle Aged; D053278:OX40 Ligand / Q000276:immunology*; D012867:Skin / Q000473:pathology; D014184:Transplantation, Homologous
D000943:Antigens, Differentiation; D053278:OX40 Ligand; C406562:OX40Ig; C089251:TNFSF4 protein, human